MassHEAL - Reducing overdose deaths by 40% (2019-2023)
MassHEAL - Reducing overdose deaths by 40% (2019-2023)
批准号:
10388200
负责人:
JEFFREY H. SAMET
金额:
$723.0万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-04-17 至 2025-03-31
关键词:
AffectAgeAutomobile DrivingCessation of lifeClinicalCollaborationsCommunicationCommunitiesCommunities That CareComplementDataData Coordinating CenterDeath RateDevelopmentDissemination and ImplementationDrug Metabolic DetoxicationEnsureEvidence based programFeedbackFentanylHealthHealth Care SectorHealth ProfessionalHealth ServicesHeroinHospitalizationImprisonmentIndividualInfrastructureInterventionLinkMassachusettsMeasuresMedicalModelingMorbidity - disease rateNaloxoneNational Institute of Drug AbuseOpioidOutcomeOverdose reductionOwnershipPersonsPharmaceutical PreparationsPhasePoliciesPopulationPreventionProcessProgram EvaluationPublic HealthRandomizedRequest for ApplicationsResearch PersonnelResourcesRisk ReductionScientistServicesSiteSpecialistTimeUnited States Substance Abuse and Mental Health Services AdministrationWorkaddictionarmbaseclinical carecommunity based participatory researchcommunity engagementcommunity interventioncostdata warehousedesigndisorder preventioneconomic evaluationeconomic impacteffective interventionexperiencehealinghigh riskimplementation facilitatorsimplementation frameworkimplementation processinnovationmodels and simulationmortalitymultidisciplinaryopioid mortalityopioid overdoseopioid useopioid use disorderopioid withdrawaloverdose deathoverdose riskprescription opioidpreventprimary outcomeprogramsrandomized trialsecondary analysissecondary outcomeservice gapshared decision makingstandard of caresuccesssynthetic opioidtreatment armtreatment as usual
中文摘要
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT
Rates of opioid overdose (OD) deaths have risen drastically in the US over the last decade; Massachusetts
(MA) is one of the hardest hit states, ranking 7th in age-adjusted OD death rate. Clinical care innovations have
led to effective interventions; unfortunately, these innovations have not become standard in many MA
communities. Using the Communities That Care (CTC) model, MassHEAL experts and community
stakeholders will utilize a data-driven approach to identify and narrow service gaps to tailor and implement a
suite of programs to reduce OD deaths in MA by 40% in 3 years. Key components will include identifying
people with opioid use disorder (OUD); providing OD risk reduction; and accelerating access to low-threshold
initiation of medications for OUD (MOUD) for high-risk individuals during hospitalization, incarceration, and
opioid detoxification. Sixteen highly impacted communities have been identified across MA. MassHEAL will
use a cluster-randomized parallel group design with communities randomized 1:1 to the intervention arm
(office-based addiction treatment [OBAT] PLUS external facilitation for communities to select from a menu of
programs and strategies, n=8) vs. a control arm (OBAT only, n=8). The MA Public Health Data (PHD)
Warehouse, which links individual-level data from more than a dozen state agencies, is a unique resource
available only in MA permitting pragmatic assessment of community- and individual-level outcomes. The
MassHEAL team exemplifies the multi-disciplinary expertise and collaborative experience necessary to
execute this study successfully. It includes clinicians who specialize in safer opioid prescribing and treatment of
OUD and have developed many of the programs proposed. This clinical team is complemented with health
services researchers, public health professionals, biostatisticians, community engagement specialists,
implementation scientists, and health economists in order to evaluate the intervention comprehensively. Using
principles of community-based participatory research (CBPR), MassHEAL has established a Community
Advisory Board that will support effective community–academic partnerships. The Specific Aims are: 1) employ
community engagement principles to develop and implement tailored clinical, prevention, and communication
strategies in MassHEAL intervention communities; 2) determine the impact of the MassHEAL intervention on
opioid OD deaths and other outcomes; 3) measure the impact of external facilitation on communities' success
implementing an OUD prevention and treatment intervention; and 4) estimate the value of the MassHEAL
community intervention relative to standard of care. MassHEAL will implement and assess a menu of
evidence-based programs to reduce opioid OD deaths in highly impacted communities across MA. Results of
this study will inform the broad dissemination and implementation of innovative medical and public health
strategies to achieve the aims of the HEALing Communities initiative across the US.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MassHEAL - Reducing overdose deaths by 40% (2019-2023)
-
批准号:10891912
-
项目类别:
-
资助金额:$79.98万
-
财政年份:2023
-
负责人:JEFFREY H. SAMET
-
依托单位:
The International URBAN Alcohol Research Collaboration on HIV/AIDS (ARCH) Center
-
批准号:10845873
-
项目类别:
-
资助金额:$37.73万
-
财政年份:2021
-
负责人:JEFFREY H. SAMET
-
依托单位:
The International Uganda Russia Boston Alcohol Network for Alcohol Research Collaboration on HIV/AIDS (URBAN ARCH) Center
-
批准号:10303983
-
项目类别:
-
资助金额:$144.51万
-
财政年份:2021
-
负责人:JEFFREY H. SAMET
-
依托单位:
Administrative Core
-
批准号:10683766
-
项目类别:
-
资助金额:$16.57万
-
财政年份:2021
-
负责人:JEFFREY H. SAMET
-
依托单位:
Administrative Core
-
批准号:10303984
-
项目类别:
-
资助金额:$18.22万
-
财政年份:2021
-
负责人:JEFFREY H. SAMET
-
依托单位:
The International URBAN Alcohol Research Collaboration on HIV/AIDS (ARCH) Center
-
批准号:10683765
-
项目类别:
-
资助金额:$142.3万
-
财政年份:2021
-
负责人:JEFFREY H. SAMET
-
依托单位:
MassHEAL - Reducing overdose deaths by 40% (2019-2023)
-
批准号:10609256
-
项目类别:
-
资助金额:$6.78万
-
财政年份:2019
-
负责人:JEFFREY H. SAMET
-
依托单位:
MassHEAL - Reducing overdose deaths by 40% (2019-2023)
-
批准号:9917749
-
项目类别:
-
资助金额:$2553.08万
-
财政年份:2019
-
负责人:JEFFREY H. SAMET
-
依托单位:
Pilot Study of Opioid-receptor Antagonists to Reduce Pain and Inflammation among HIV-Infected Persons with Alcohol Problems
-
批准号:10019309
-
项目类别:
-
资助金额:$35.46万
-
财政年份:2019
-
负责人:JEFFREY H. SAMET
-
依托单位:
Pilot Study of Opioid-receptor Antagonists to Reduce Pain and Inflammation among HIV-Infected Persons with Alcohol Problems
-
批准号:9985430
-
项目类别:
-
资助金额:$32.4万
-
财政年份:2019
-
负责人:JEFFREY H. SAMET
-
依托单位:
MassHEAL - Reducing overdose deaths by 40% (2019-2023)
-
批准号:10351640
-
项目类别:
-
资助金额:$6.78万
-
财政年份:2019
-
负责人:JEFFREY H. SAMET
-
依托单位:
MassHEAL - Reducing overdose deaths by 40% (2019-2023)
-
批准号:10400445
-
项目类别:
-
资助金额:$1.48万
-
财政年份:2019
-
负责人:JEFFREY H. SAMET
-
依托单位:
Linking Russian Narcology and HIV Care to Enhance Treatment, Retention and Outcomes Part II
-
批准号:9982283
-
项目类别:
-
资助金额:$68.24万
-
财政年份:2017
-
负责人:JEFFREY H. SAMET
-
依托单位:
Linking Russian Narcology and HIV Care to Enhance Treatment, Retention and Outcomes Part II
-
批准号:10220004
-
项目类别:
-
资助金额:$71.88万
-
财政年份:2017
-
负责人:JEFFREY H. SAMET
-
依托单位:
Improving Physician Opioid Prescribing for Chronic Pain in HIV-infected Persons
-
批准号:8729165
-
项目类别:
-
资助金额:$110.56万
-
财政年份:2014
-
负责人:JEFFREY H. SAMET
-
依托单位:
Improving Physician Opioid Prescribing for Chronic Pain in HIV-infected Persons
-
批准号:8920118
-
项目类别:
-
资助金额:$110.65万
-
财政年份:2014
-
负责人:JEFFREY H. SAMET
-
依托单位:
Alcohol & Zinc Impact on Inflammatory Markers in HIV Disease - Russia ARCH Cohort
-
批准号:8599673
-
项目类别:
-
资助金额:$6.16万
-
财政年份:2013
-
负责人:JEFFREY H. SAMET
-
依托单位:
Linking Russian Narcology & HIV Care to Enhance Treatment, Retention, & Outcomes
-
批准号:8190144
-
项目类别:
-
资助金额:$70.33万
-
财政年份:2011
-
负责人:JEFFREY H. SAMET
-
依托单位:
URBAN ARCH (1/5) Administrative Coordinating Core (Admin Core)
-
批准号:9757648
-
项目类别:
-
资助金额:$26.29万
-
财政年份:2011
-
负责人:JEFFREY H. SAMET
-
依托单位:
Linking Russian Narcology & HIV Care to Enhance Treatment, Retention, & Outcomes
-
批准号:8302232
-
项目类别:
-
资助金额:$65.16万
-
财政年份:2011
-
负责人:JEFFREY H. SAMET
-
依托单位:
国内基金
海外基金
登录
查看更多内容
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
-
批准号:JCZRLH202601523
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2026
-
负责人:
-
依托单位:
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
-
批准号:JCZRQN202500010
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:
-
依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
-
批准号:2025JJ70209
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2025
-
负责人:雷芬芳
-
依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
-
批准号:--
-
项目类别:面上项目
-
资助金额:--
-
批准年份:2024
-
负责人:万荣
-
依托单位:
甜茶抑制AGE-RAGE通路增强突触可塑性改善小鼠抑郁样行为
-
批准号:2023JJ50274
-
项目类别:省市级项目
-
资助金额:--
-
批准年份:2023
-
负责人:贺志明
-
依托单位:
蒙药额尔敦-乌日勒基础方调控AGE-RAGE信号通路改善术后认知功能障碍研究
-
批准号:--
-
项目类别:地区科学基金项目
-
资助金额:33万元
-
批准年份:2022
-
负责人:都义日
-
依托单位:
补肾健脾祛瘀方调控AGE/RAGE信号通路在再生障碍性贫血骨髓间充质干细胞功能受损的作用与机制研究
-
批准号:--
-
项目类别:面上项目
-
资助金额:52万元
-
批准年份:2022
-
负责人:叶宝东
-
依托单位:
LncRNA GAS5在2型糖尿病动脉粥样硬化中对AGE-RAGE 信号通路上相关基因的调控作用及机制研究
-
批准号:
-
项目类别:省市级项目
-
资助金额:10.0万元
-
批准年份:2022
-
负责人:于海兵
-
依托单位:
围绕GLP1-Arginine-AGE/RAGE轴构建探针组学方法探索大柴胡汤异病同治的效应机制
-
批准号:81973577
-
项目类别:面上项目
-
资助金额:55.0万元
-
批准年份:2019
-
负责人:辛贵忠
-
依托单位:
AGE/RAGE通路microRNA编码基因多态性与2型糖尿病并发冠心病的关联研究
-
批准号:81602908
-
项目类别:青年科学基金项目
-
资助金额:18.0万元
-
批准年份:2016
-
负责人:刘括
-
依托单位: